Trophic effect of human pericardial fluid on adult cardiac myocytes: Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy

Circulation Research

Volumn 81, Issue 5, 1997, Pages 679-687

  Corda, Stefano ^a   Mebazaa, Alexandre ^a,c   Gandolfini, Maria Pia ^b   Fitting, Catherine ^d   Marotte, Françoise ^b   Peynet, Jacqueline ^c   Charlemagne, Danièle ^b   Cavaillon, Jean Marc ^d   Payen, Didier ^a   Rappaport, Lydie ^b   Samuel, Jane Lyse ^b  

^a Dept d'Anesthesie Reanimation   (France)

^b 'Lipoproteines et A   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d INSTITUT PASTEUR   (France)

Author keywords

Growth factor; Heart; Human cardiomyopathy; Protein synthesis; Serum

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANIMAL CELL; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HUMAN; MALE; NONHUMAN; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

EID: 0030716370     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.5.679     Document Type: Article

References (52)

1. Brutsaert DL, Andries LJ. The endocardial endothelium. Am J Physiol. 1992;263:H985-H1002.
2. Shah AM. Paracrine modulation of heart cell function by endothelial cells. Cardiovascular Res. 1996;31:847-867.
3. Ramaciotti C, Sharkey A, McClellan G, Winegrad S. Endothelial cells regulate cardiac contractility. Proc Nat Acad Sci U S A. 1992;89:4033-4036.
4. Mebazaa A, Mayoux E, Maeda K, Martin LD, Lakatta EG, Robotham JR, Shall AM. Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am J Physiol. 1993;265:H1841-H1846.
5. Shah AM, Mebazaa A., Wetzel RC, Lakatta EG. A novel cardiac myofilament desensitizing factor released by endocardial and vascular endothelial cells. Circulation. 1994;89:2492-2497.
6. Schneider MD, Parker TG. Cardiac myocytes as targets for the action of peptide growth factors. Circulation. 1990;81:1443-1456.
7. Pasumarthi KBS, Kardami E, Cattini PA. High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology: evidence for both paracrine and intracrine actions of fibroblast growth factor-2. Circ Res. 1996;78:126-136.
8. Takahashi N, Calderone A, Izzo NJ, Maki T, Marsh J, Colucci WS. Hypertrophic stimuli induce transforming growth factor-β1 expression in rat ventricular myocytes. J Clin Invest. 1994;94:1470-1476.
9. Speir E, Tanner V, Gonzalez AM, Farris J, Baird A, Casscells W. Acidic and basic fibroblast growth factors in adult rat heart myocytes: localization, regulation in culture, and effects on DNA synthesis. Circ Rev. 1992;71:251-259.
10. Weiner HL, Swain JL. Acidic fibroblast growth factor mRNA is expressed in cardiac myocytes in culture and the protein is localized to the extracellular matrix. Proc. Natl Acad Sci U S A 1989;86:2683-2687.
11. Roberts AB, Roche NS, Winokur TS, Burmester JK, Sporn MB. Role of transforming growth factor-β in maintenance of function of cultured neonatal cardiac myocytes. J Clin Invest. 1992;90:2056-2062.
12. Kardami E, Fandrich R. Basic fibroblast growth factor in atria and ventricles of vertebrates hearts. J Cell Biol. 1989:109:1865-1875.
13. Liu L, Pasumarthi KBS, Padua R, Massaeli H, Fandrich R, Pierce GN, Cattini PA, Kardami E. Adult cardiomyocytes express functional high affinity receptors for basic fibroblast growth factor. Am J Physiol. 1995;37:H1927-H1938.
14. Casscells W, Speir E, Sasse J, Klagsbrun M, Allen P, Lee M, Calvo B, Chiba M, Haggroth L, Folkman J, Epstein SE. Isolation, characterization and localization of heparin-binding growth factors in the heart. J Clin Invest. 1990;85:433-441.
15. Hammond GL, Wieber E, Markert CL. Molecular signals initiating protein synthesis in organ hypertrophy. Proc Natl Acad Sci U S A. 1979;76:2455-2459.
16. Long CS, Kariya K, Karns L, Simpson PC. Trophic factors for cardiac myocytes. J Hypertens. 1990;8:S219-S224.
17. Yu JZ, Bondy GP, Allard MF, Thompson CR, Levin A. McManus BM. Serum from patients with chronic renal insufficiency alters growth characteristics and ANP inRNA expression of adult cardiac myocytes. J Mol Cell Cardiol. 1996;28:2429-2441.
18. Gibson T, Segal MB. A study of the composition of pericardial fluid, with special reference to the probable mechanism of fluid formation. J Physiol (Lond). 1978;277:367-377.
19. Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T, Tamaki S, Yamazato A, Sasayama S. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation. 1996;94:610-613.
20. Clarke MSF, Caldwell RW, Chiao H, Miyake K, McNeil P. Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ Res. 1995;76:927-934.
21. Page E, Upshaw-Earley J, Goings G. Permeability of rat atrial endocardium, epicardium, and myocardium to large molecules: stretch-dependent effects. Circ Res. 1992;71:159-173.
22. Kaye D, Pimental D, Prasay S, Maki T, Berger HJ, McNeil PL, Smith TW, Kelly RA. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest. 1996;97:281-291.
23. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
24. Marie C, Cavaillon JM, Losser MR. Elevated levels of circulating transforming growth factor β in patients with sepsis syndrome. Ann Intern Med. 1996;125:520-521.
25. Dubus I, Samuel J-L, Marotte F, Delcayre C, Rappaport L. β-Adrenergic agonists stimulate the synthesis of noncontractile but not contractile proteins in cultured myocytes isolated from adult rat heart. Circ Res. 1990;66:867-874.
26. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;196:248-254.
27. Schiaffino S, Samuel JL, Sassoon D, Lompré AM, Garner I, Marotte F, Buckingham M, Rappaport L, Schwartz K. Nonsynchronous accumulation of α-skeletal actin and β-myosin heavy chain mRNAs during early stages of pressure-overload-induced cardiac hypertrophy demonstrated by in situ hybridization. Circ Res. 1989;64:937-948.
28. Dubus I, Mercadier A, Lucas O, Contard F, Nallet O, Oliviero P, Rappaport L, Samuel JL. α-, β-MHC mRNA quantification in adult cardiomyocytes by in situ hybridization: effect of thyroid hormone. Am J Physiol. 1993;34:C62-C71.
29. Wakefield LM, Smith DM, Flanders KC, Sporn MB. Latent transforming growth factor-β from human platelets. J Biol Chem. 1988;263:7646-7654.
30. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein (a) mice. Nature. 1994;370:460-462.
31. Roberts A, Sporn M. The transforming growth factors-βs. In: Sporn M. Roberts A, eds. Peptide Growth Factors and Their Receptors. New York, NY: Springer-Verlag; 1991:419-472.
32. Cacoub P, Dorent R, Nataf P, Carayon A, Maistre G, Piette JC, Godeau P, Cabrol C, Gandjbakhch I. Plasma endothelin and pulmonary pressures in patients with congestive heart failure. Am Heart J. 1993;126:1484-1488.
33. Nadal-Ginard B, Mahdavi V, Molecular basis of cardiac performance. J Clin Invest. 1989;84:1693-1700.
34. Parker T, Packer S, Schneider M. Peptide growth factors can provoke 'fetal' contractile protein gene expression in rat cardiac myocyte. J Clin Invest. 1990;85:507-514.
35. Kardami E. Stimulation and inhibition of cardiac myocyte proliferation in vitro. Mol Cell Biochem. 1990;92:129-135.
36. Samuel JL, Dubus F. Farhadian F, Marotte F, Oliviero P, Mercadier A, Contard F, Barrieux A, Rappaport L. Multifactorial regulation of cardiac gene expression: an in vivo and in vitro analysis. Ann N Y Acad Sci. 1995;752:371-386.
37. Amano J, Suzuki A, Sunamori M, Schichiri M, Marumo F. Atrial natriuretic peptide in the pericardial fluid of patients with heart disease. Clin Sci (Colch). 1993;85:165-168.
38. Kardami E, Liu L, Kishore S, Pasumarthi B, Doble BW, Cattini P. Regulation of basic fibroblast growth factor (bFGF) and FGF receptors in the heart. Ann N Y Acad Sci. 1995;752:353-369.
39. Schneider MD, Parker TG. Molecular mechanism of cardiac growth and hypertrophy: myocardial growth factors and protoon-cogenes in development and disease. In: Roberts R. ed. Molecular Basis of Cardiology. New York, NY: Blackwell Scientific Publications; 1993:113-134.
40. Frelin C, Guedin D. Why are circulating concentrations of endothelin so low? Cardiovasc Res. 1994;28:1613-1622.
41. Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall C, Parker P, Sugden PH. Endothelin-1 and fibroblast growth factor stimulate the mitogen activated protein kinase signalling cascade in cardiac myocytes. J Biol Chem. 1994;269:1110-1119.
42. Baird A, Durkin T. Inhibition of endothelial cell proliferation by type beta transforming growth factor: interaction s with acidic and basic fibroblast growth factor. Biochem Biophys Res Commun. 1986;138:476-482.
43. Kirschenlohr HL, Metcalfe J, Weissberg PL, Grainger DJ. Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGF-β. Cardiovasc Res. 1995;29:848-855.
44. McPherron A, Lawler A, Lee S. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature. 1997;387:83-90.
45. Lyons RM, Jorma KO, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol. 1989;106:1659-1665.
46. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Marumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat myocytes. J Clin Invest. 1993;42:398-403.
47. Sadoshima J, Xu Y, Slayter H, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytcs in vitro. Cell. 1993;75:977-984.
48. Fishel RS, Thourani V, Eisenberg S, Shai SY, Cursor, MA, Nabel EG, Bernstein KE, Berk BC. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells: possible mediator of the response to vascular injury. J Clin Invest. 1995;95:377-387.
49. Booz G, Baker K, Role of type 1 and type 2 angiotensin receptor in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension. 1996;28:635-640.
50. Mercadier JJ, Samuel JL, Michel JB, Zongazo M, De la Bastie A, Lompré AM, Wisnewsky C, Rappaport L, Levy B, Schwartz K. Atrial natriuretic factor gene expression in rat ventricle during experimental hypertension. Am J Physiol. 1989;257:H979-H987.
51. Sadoshima J, Izumo S. Mechanical stress rapidly activates multiple signal transduction pathways in cardiac myocytes/potential involvement of an autocrine-paracrine mechanism. EMBO J. 1993;12:1681-1692.
52. Itoh H, Pratt R, Dzau V. Atrial natriuretic peptides inhibits hypertrophy of vascular smooth muscle cells. J Clin invest. 1990;86:1690-1697.